# A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

> **NCT07300839** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **BioNTech SE** · enrollment: 5240 (actual)

## Conditions studied

- COVID-19
- SARS-COV-2 Infection

## Interventions

- **BIOLOGICAL:** BNT162b2 Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07300839
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 5240 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300839, "A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07300839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*